Here are six quick facts about the transaction:
1. Mr. Lucier purchased 10,000 NuVasive shares.
2. The shares were purchased at $49.71 per share.
3. The total transaction reached $497,100.
4. Company shares rallied 41.61 percent from the one-year high price.
5. Company insiders hold 1.54 percent of shares and institutions hold 99 percent of shares.
6. NuVasive’s market cap is $2.3 billion.
More articles on orthopedic devices:
10 trends to note in the knee implant market
8 trends in the North American neurosurgery market
5 predictions about the 2012-2018 bio-implant market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
